Surmodics

Surmodics Free Cash Flow

Delisted

The Free Cash Flow (FCF) of Surmodics (SRDX) as of Nov 17, 2026 is -3.24 M USD. In the previous year, Free Cash Flow (FCF) was 7.60 M USD — a change of -142.71% (lower).

Free Cash Flow

-3.24 MUSD

YoY

-142.71%

Last updated:

Free Cash Flow (FCF) of Surmodics is 2024 -3.24 M USD. Free Cash Flow (FCF) of Surmodics was 2023 7.60 M USD. It decreases by -142.71% lower compared to the previous year.

The Surmodics Free Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Free Cash Flow
Date
Free Cash Flow
Jan 1, 2017
7.62 M USD
Jan 1, 2018
19.96 M USD
Jan 1, 2019
1.29 M USD
Jan 1, 2020
10.34 M USD
Jan 1, 2021
9.11 M USD
Jan 1, 2022
-20.59 M USD
Jan 1, 2023
7.60 M USD
Jan 1, 2024
-3.24 M USD
The Surmodics Free Cash Flow history
YEARFree Cash FlowYoY
-3.24 MUSD-142.71%
7.60 MUSD-136.89%
-20.59 MUSD-326.05%
9.11 MUSD-11.89%
10.34 MUSD+701.47%
1.29 MUSD-93.54%
19.96 MUSD+161.91%
7.62 MUSD-55.10%
16.97 MUSD+29.14%
13.14 MUSD-17.37%
15.91 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Surmodics Stock analysis

What does Surmodics do? Surmodics Inc is an American company specializing in medical technology, based in Eden Prairie, Minnesota. They focus on developing and commercializing technologies to improve disease diagnosis and treatment. The company offers a wide range of medical devices and solutions for various medical applications, including cardiology, radiology, oncology, ophthalmology, and pharmaceutical development. Surmodics operates in three main business areas: medical devices, hollow fiber technology, and bioactive coatings. Their products are designed to meet the specific needs of customers and medical applications. Surmodics has a strong global presence and has expanded through strategic acquisitions in recent years, particularly in the pharmaceutical development and hollow fiber technology sectors. Surmodics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Surmodics stock

Free Cash Flow (FCF) of Surmodics is -3.24 M USD in 2024.

Free Cash Flow (FCF) of Surmodics changed from 7.60 M USD to -3.24 M USD, representing a -142.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) Surmodics since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s Surmodics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Surmodics

All Key Metrics — Surmodics